“Cleveland Clinic: Millions of COVID-vaxxed will die within ‘5 years,’” the headline said. This Facebook post was flagged as ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Thousands of people were laid off Tuesday at the United States' top health agencies. Here are what positions and efforts were ...

Key Takeaways The U.S. Food and Drug Administration has delayed full approval of Novavax's COVID vaccineThe agency says it needs more data before making a final decisionNovavax says its vaccine is ...

The FDA, which typically handles medication access changes, hasn’t approved ivermectin to treat or prevent COVID-19.

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Moderna, Baxter, and Pfizer are our top healthcare picks.

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

In what appears to be the near end of this year’s Idaho legislative session, Idaho Republican legislative leaders are backing ...